Piramal Pharma surges 4% after launching drug for psychiatric disorders

Piramal Pharma share price gained 3.87 per cent at Rs 252.05 a piece on the BSE in Thursday’s intraday trade. This came after Piramal Pharma’s division Piramal Critical Care (PCC) announced the US launch of Chlorpromazine Hydrochloride Injection which will be offered in 25mg/1mL and 50mg/2 mL vials .
Chlorpromazine Hydrochloride Injection is a medication primarily used to treat a range of psychiatric disorders, including schizophrenia and other psychotic conditions such as paranoia (delusions and intense feelings of worry or nervousness), mania (excessive activity and energy), anxiety, agitation, and impulsive behavior that may be dangerous.
PCC has introduced Chlorpromazine Hydrochloride, marking another addition to its growing portfolio of generic injectables. This launch follows the introduction of Edaravone IV Infusion in 2024. In 2023, PCC further expanded its portfolio with the launches of Pantoprazole Sodium for Injection, USP, and Doxycycline for Injection, USP, underscoring its commitment to providing a comprehensive range of critical care products, the company said in a statement.

Related Posts

  • Pharma
  • July 16, 2025
  • 126 views
Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Generic drugmakers Aurobindo Pharma, Cipla and Viatris will develop, manufacture and supply long-acting injectable cabotegravir (CAB LA) for HIV treatment in 133 countries. This follows ViiV Healthcare, a company focused…

  • Pharma
  • July 16, 2025
  • 40 views
Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

The pharma sector will be in focus on July 16, after Donald Trump said that pharmaceuticals tariffs would be implemented soon. Shares of pharmaceutical companies traded flat on Wednesday, July…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Aurobindo, Cipla, Viatris to make, market long-acting injectable HIV drug

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Pharma stocks hover near flatline even as Trump hints at new tariffs by July-end

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Govt revises prices of 71 medicines, including those for diabetes and infections: Check new rates

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.

Sun Pharma reaches settlement with Incyte Corporation, launches Leqselvi in U.S.